Literature DB >> 18339896

Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Jing Chen1, Mike Petrus, Bonita R Bryant, Vinh Phuc Nguyen, Mindy Stamer, Carolyn K Goldman, Richard Bamford, John C Morris, John E Janik, Thomas A Waldmann.   

Abstract

The etiologic agent of adult T-cell leukemia (ATL) is human T cell lymphotropic virus type I (HTLV-I). The HTLV-I protein Tax alters gene expression, including those of cytokines and their receptors, which plays an important role in early stages of ATL. Here we demonstrate that expression of interleukin-9 (IL-9) is activated by Tax via an NF-kappaB motif in its proximal promoter, whereas IL-9 receptor-alpha (IL-9Ralpha) expression is not induced by Tax. However, supporting a role for IL-9/IL-9Ralpha in ATL, a neutralizing monoclonal antibody directed toward IL-9Ralpha inhibited ex vivo spontaneous proliferation of primary ATL cells from several patients. Fluorescence-activated cell sorter analysis of freshly isolated peripheral blood mononuclear cells from these patients revealed high level expression of IL-9Ralpha on their CD14-expressing monocytes. Furthermore, purified T cells or monocytes alone from these patients did not proliferate ex vivo, whereas mixtures of these cell types manifested significant proliferation through a contact-dependent manner. Taken together, our data suggest that primary ATL cells, via IL-9, support the action of IL-9Ralpha/CD14-expressing monocytes, which subsequently support the ex vivo spontaneous proliferation of malignant T cells. In summary, these data support a role for IL-9 and its receptor in ATL by a paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339896      PMCID: PMC2384140          DOI: 10.1182/blood-2007-09-113654

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cell.

Authors:  S Kubota; H Siomi; M Hatanaka; R J Pomerantz
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

2.  Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells.

Authors:  Y Yamada; K Sugawara; T Hata; K Tsuruta; R Moriuchi; T Maeda; S Atogami; K Murata; K Fujimoto; T Kohno; K Tsukasaki; M Tomonaga; Y Hirakata; S Kamihira
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

3.  Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site.

Authors:  N Azimi; K Brown; R N Bamford; Y Tagaya; U Siebenlist; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.

Authors:  S Tamiya; M Matsuoka; K Etoh; T Watanabe; S Kamihira; K Yamaguchi; K Takatsuki
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

5.  Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.

Authors:  I Elovaara; U Utz; S Smith; S Jacobson
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

6.  Frequent expression of interleukin-9 mRNA and infrequent involvement of interleukin-9 in proliferation of primary adult T-cell leukemia cells and HTLV-I infected T-cell lines.

Authors:  K Matsushita; N Arima; H Ohtsubo; H Fujiwara; S Hidaka; J Fukumori; H Tanaka
Journal:  Leuk Res       Date:  1997-03       Impact factor: 3.156

7.  Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells.

Authors:  K Kelleher; K Bean; S C Clark; W Y Leung; T L Yang-Feng; J W Chen; P F Lin; W Luo; Y C Yang
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

8.  Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B.

Authors:  T Kanno; K Brown; G Franzoso; U Siebenlist
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

Review 9.  Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis.

Authors:  J C Renauld; A Kermouni; A Vink; J Louahed; J Van Snick
Journal:  J Leukoc Biol       Date:  1995-03       Impact factor: 4.962

10.  Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.

Authors:  H E Prince; J York; J Golding; S M Owen; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
View more
  33 in total

1.  Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

2.  Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.

Authors:  Unsong Oh; Matthew J McCormick; Dibyadeep Datta; Richard V Turner; Kathryn Bobb; Dileep D Monie; D Robert Sliskovic; Yuetsu Tanaka; Jie Zhang; Jeffrey Meshulam; Steven Jacobson
Journal:  Blood       Date:  2011-01-06       Impact factor: 22.113

3.  Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.

Authors:  Alaa Refaat; Yue Zhou; Shunsuke Suzuki; Ichiro Takasaki; Keiichi Koizumi; Shoji Yamaoka; Yoshiaki Tabuchi; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

4.  Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Authors:  Jonathan L Berkowitz; John E Janik; Donn M Stewart; Elaine S Jaffe; Maryalice Stetler-Stevenson; Joanna H Shih; Thomas A Fleisher; Maria Turner; Nicole E Urquhart; Gilian H Wharfe; William D Figg; Cody J Peer; Carolyn K Goldman; Thomas A Waldmann; John C Morris
Journal:  Clin Immunol       Date:  2014-09-28       Impact factor: 3.969

Review 5.  Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

Authors:  Thomas A Waldmann; Jing Chen
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

6.  An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.

Authors:  Mathew A Cherian; Sydney Olson; Hemalatha Sundaramoorthi; Kitra Cates; Xiaogang Cheng; John Harding; Andrew Martens; Grant A Challen; Manoj Tyagi; Lee Ratner; Daniel Rauch
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

7.  Role of high expression of IL-9 in prognosis of CLL.

Authors:  Na Chen; Xiao Lv; Peipei Li; Kang Lu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 8.  Th9 and allergic disease.

Authors:  Pejman Soroosh; Taylor A Doherty
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

9.  Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Raya Massoud; Yoshimi Enose-Akahata; Yutaka Tagaya; Nazli Azimi; Asjad Basheer; Steven Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 10.  Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.

Authors:  Masaya Higuchi; Masahiro Fujii
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.